e-learning
resources
Milan 2017
Tuesday, 12.09.2017
IPF: from the bench to the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis
L. De Sadeleer (LEUVEN, Belgium)
Source:
International Congress 2017 – IPF: from the bench to the bedside
Session:
IPF: from the bench to the bedside
Session type:
Thematic Poster
Number:
3814
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. De Sadeleer (LEUVEN, Belgium). Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis. 3814
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015
Progression of Idiopathic Pulmonary Fibrosis in patients with past occupational exposure to dusts
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017
Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020
IPF - Idiopathic Pulmonary Fibrosis
Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152
Year: 2019
Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF)
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – M-health/e-health I
Year: 2019
Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019
Idiopathic Pulmonary Fibrosis (IPF)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019
Implication of FGFR4 and its ligands in Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Association between severity of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis?
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept